EZH2 and neoplasm: LINC00152 can also promote the growth of tumor cells, both in vivo and in vitro, by binding enhancer of zeste homolog 2 (EZH2) and regulating the CXC motif chemokine ligand 9 (CXCL9) and CXCL10/CXCR3 axes in CD8T cells (69).